4.7 Article

Recent Nationwide Trends in Discharge Statin Treatment of Hospitalized Patients With Stroke

Journal

STROKE
Volume 41, Issue 7, Pages 1508-1513

Publisher

LIPPINCOTT WILLIAMS & WILKINS
DOI: 10.1161/STROKEAHA.109.573618

Keywords

clinical trials; GWTG; health services; practice patterns; prevention; statins; stroke; transient ischemic attack; utilization

Funding

  1. AHA
  2. ASA
  3. Pfizer, Inc, New York, NY
  4. Merck-Schering Plough Partnership (North Wales, Pa)
  5. National Institutes of Health (National Institute of Neurological Disorders and Stroke) [R01 NS062028]
  6. Canadian Stroke Network
  7. Heart and Stroke Foundation of Canada
  8. Canadian Institute for Health Research
  9. Johnson Johnson
  10. Medtronic
  11. Merck

Ask authors/readers for more resources

Background and Purpose-The Stroke Prevention by Aggressive Reduction in Cholesterol Levels (SPARCL) trial showed statins reduce vascular risk among patients with atherosclerotic stroke or transient ischemic attack. In this study, we assessed recent nationwide trends in discharge statin treatment after acute stroke and the influence of SPARCL on clinical practice. Methods-Using data from eligible patients with stroke and transient ischemic attack admitted to Get With The Guidelines-Stroke (GWTG-Stroke)-participating hospitals between January 1, 2005, and December 31, 2007, we assessed discharge statin use over time and in relation to dissemination of the SPARCL results. Results-Among 173 284 patients with ischemic stroke and transient ischemic attack, overall discharge statin treatment was 83.5%. Discharge statin prescription climbed steadily but modestly over the 2-year study period from 75.7% to 84.8% (P<0.001) with a nonsignificant increase during SPARCL reporting but a return to prior levels thereafter. Factors associated with lower discharge statin use in patients without contraindications included female sex and South region. Conclusions-Discharge statin prescription among hospitalized patients with stroke increased over time, but 1 in 5 patients still leaves the hospital without treatment. Primary drivers of increased use were secular trends and individual/hospital site characteristics. (Stroke. 2010; 41: 1508-1513.)

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.7
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

Article Clinical Neurology

Vascular burden and cognition: Mediating roles of neurodegeneration and amyloid PET

Julie Ottoy, Miracle Ozzoude, Katherine Zukotynski, Sabrina Adamo, Christopher Scott, Vincent Gaudet, Joel Ramirez, Walter Swardfager, Hugo Cogo-Moreira, Benjamin Lam, Aparna Bhan, Parisa Mojiri, Min Su Kang, Jennifer S. Rabin, Alex Kiss, Stephen Strother, Christian Bocti, Michael Borrie, Howard Chertkow, Richard Frayne, Robin Hsiung, Robert Laforce, Michael D. Noseworthy, Frank S. Prato, Demetrios J. Sahlas, Eric E. Smith, Phillip H. Kuo, Vesna Sossi, Alexander Thiel, Jean-Paul Soucy, Jean-Claude Tardif, Sandra E. Black, Maged Goubran

Summary: This study investigated the association between cerebrovascular burden and cognitive function, and found that the relationship was mainly mediated by localized neurodegeneration rather than amyloid beta deposition. The results suggest an amyloid-independent pathway through which vascular burden affects cognitive function.

ALZHEIMERS & DEMENTIA (2023)

Article Clinical Neurology

A Causal Classification System for Intracerebral Hemorrhage Subtypes

Nicolas Raposo, Maria Clara Zanon Zotin, David J. Seiffge, Qi Li, Martina B. Goeldlin, Andreas Charidimou, Ashkan Shoamanesh, Hans Rolf Jager, Charlotte Cordonnier, Catharina Jm Klijn, Eric E. Smith, Steven M. Greenberg, David J. Werring, Anand Viswanathan

Summary: The study developed a new classification system called CLAS-ICH for subtyping intracerebral hemorrhage (ICH) based on recent advances in neuroimaging. The system assigns scores to each category to determine the underlying causes of ICH. The system was validated in two cohorts and demonstrated reliability and consistency.

ANNALS OF NEUROLOGY (2023)

Article Geriatrics & Gerontology

Treatment of Vascular and Neurodegenerative Forms of Cognitive Impairment and Dementias

Landon Perlett, Eric E. Smith

CLINICS IN GERIATRIC MEDICINE (2023)

Review Cardiac & Cardiovascular Systems

Managing Heart Failure in Patients on Dialysis: State-of-the-Art Review

Muhammad Shahzeb Khan, Aymen Ahmed, Stephen J. Greene, Mona Fiuzat, Michelle M. Kittleson, Javed Butler, George L. Bakris, Gregg C. Fonarow

Summary: Heart failure and end-stage kidney disease often coexist and worsen each other's prognosis. Patients on dialysis are at high risk, but they have been excluded from major clinical trials on heart failure, resulting in a lack of data and reliance on observational evidence. In clinical practice, heart failure treatment is often reduced or discontinued in patients with end-stage kidney disease undergoing dialysis due to safety concerns. This review discusses the available evidence, challenges, and future directions for optimizing heart failure management in these high-risk patients.

JOURNAL OF CARDIAC FAILURE (2023)

Article Medicine, General & Internal

Recent Vitamin K Antagonist Use and Intracranial Hemorrhage After Endovascular Thrombectomy for Acute Ischemic Stroke

Brian Mac Grory, DaJuanicia N. Holmes, Roland A. Matsouaka, Shreyansh Shah, Cherylee W. J. Chang, Richard Rison, Jenelle Jindal, Christine Holmstedt, William R. Logan, Candy Corral, Jason S. Mackey, Joey R. Gee, David Bonovich, James Walker, Toby Gropen, Curtis Benesch, Jonathan Dissin, Hemant Pandey, David Wang, Martin Unverdorben, Adrian F. Hernandez, Mathew Reeves, Eric E. Smith, Lee H. Schwamm, Deepak L. Bhatt, Jeffrey L. Saver, Gregg C. Fonarow, Eric D. Peterson, Ying Xian

Summary: The use of oral vitamin K antagonists (VKAs) may increase the risk of complications for patients undergoing endovascular thrombectomy for acute ischemic stroke caused by large vessel occlusion. Recent use of VKAs with an international normalized ratio (INR) greater than 1.7 is associated with a significantly higher risk of symptomatic intracranial hemorrhage (sICH) compared to no use of anticoagulants.

JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2023)

Article Clinical Neurology

Mechanistic Implications of Cortical Superficial Siderosis in Patients With Mixed Location Intracerebral Hemorrhage and Cerebral Microbleeds

Alvin S. S. Das, Elif Gokcal, Alessandro Biffi, Robert W. W. Regenhardt, Marco Pasi, Avia A. Abramovitz Fouks, Anand Viswanathan, Joshua Goldstein, Lee H. H. Schwamm, Jonathan Rosand, Steven M. M. Greenberg, M. Edip Gurol

Summary: This study examined the association between cerebral amyloid angiopathy (CAA) markers and mixed intracerebral hemorrhage (ICH) with cortical superficial siderosis (cSS). The results showed that patients with mixed ICH/cSS(+) had higher frequencies of CAA imaging markers and a higher risk of ICH recurrence compared to patients without cSS.

NEUROLOGY (2023)

Article Clinical Neurology

Association of Tirofiban With Functional Outcomes After Thrombectomy in Acute Ischemic Stroke Due to Intracranial Atherosclerotic Disease

Hongfei Sang, Dongjing Xie, Yan Tian, Thanh N. Nguyen, Jeffrey L. Saver, Raul G. Nogueira, Junxiong Wu, Chen Long, Zhenxuan Tian, Zhizhou Hu, Tao Wang, Rongzong Li, Yingbing Ke, Xiurong Zhu, Daizhou Peng, Mingze Chang, Lingfei Li, Jie Ruan, Deping Wu, Wenjie Zi, Qingwu Yang, Fengli Li, Zhongming Qiu

Summary: This study investigated the efficacy and safety of IV infusion of tirofiban before endovascular thrombectomy for patients with large vessel occlusion due to intracranial atherosclerotic disease. The results showed that patients in the tirofiban group had higher rates of functional independence at 90 days without increased risk of mortality or symptomatic intracranial hemorrhage. The reduction of thrombectomy passes mediated a significant portion of the effect of tirofiban on functional independence.

NEUROLOGY (2023)

Article Health Care Sciences & Services

Comparison of Machine Learning Algorithms for Predicting Hospital Readmissions and Worsening Heart Failure Events in Patients With Heart Failure With Reduced Ejection Fraction: Modeling Study

Boshu Ru, Xi Tan, Yu Liu, Kartik Kannapur, Dheepan Ramanan, Garin Kessler, Dominik Lautsch, Gregg Fonarow

Summary: This study aimed to compare different machine learning prediction models and feature construction methods to predict readmissions and worsening heart failure events (WHFEs) in patients with heart failure with reduced ejection fraction (HFrEF). The results showed that the XGBoost model with the frequency of clinical codes as features had the best discriminative ability for predicting these events.

JMIR FORMATIVE RESEARCH (2023)

Article Neuroimaging

Tigertriever in the treatment of acute ischemic stroke with underlying intracranial atherosclerotic disease

Diego J. Ojeda, Malik Ghannam, Sebastian Sanchez, Mohammad Almajali, Prateeka Koul, Jeffrey L. Saver, Rishi Gupta, Santiago Ortega-Gutierrez, Edgar A. Samaniego

Summary: The Tigertriever device shows high success rate and short puncture to reperfusion time in patients with large vessel occlusion and underlying intracranial atherosclerotic disease, without device-related complications.

JOURNAL OF NEUROINTERVENTIONAL SURGERY (2023)

Article Clinical Neurology

Progression of cerebral amyloid angiopathy: a pathophysiological framework

Emma A. Koemans, Jasmeer P. Chhatwal, Susanne J. van Veluw, Ellis S. van Etten, Matthias J. P. van Osch, Marianne A. A. van Walderveen, Hamid R. Sohrabi, Mariel G. Kozberg, Zahra Shirzadi, Gisela M. Terwindt, Mark A. van Buchem, Eric E. Smith, David J. Werring, Ralph N. Martins, Marieke J. H. Wermer, Steven M. Greenberg

Summary: Cerebral amyloid angiopathy, a common age-related small vessel pathology, is associated with intracerebral haemorrhage and cognitive impairment. By studying individuals with different forms of the disease and using mouse models, researchers have identified key stages in the progression of cerebral amyloid angiopathy, which may help in developing interventions for this and other cerebral small vessel diseases.

LANCET NEUROLOGY (2023)

Review Clinical Neurology

Neuroimaging standards for research into small vessel disease-advances since 2013

Marco Duering, Geert Jan Biessels, Amy Brodtmann, Christopher Chen, Charlotte Cordonnier, Frank-Erik de Leeuw, Stephanie Debette, Richard Frayne, Eric Jouvent, Natalia S. Rost, Annemieke ter Telgte, Rustam Al-Shahi Salman, Walter H. Backes, Hee-Joon Bae, Rosalind Brown, Hugues Chabriat, Alberto De Luca, Charles deCarli, Anna Dewenter, Fergus N. Doubal, Michael Ewers, Thalia S. Field, Aravind Ganesh, Steven Greenberg, Karl G. Helmer, Saima Hilal, Angela C. C. Jochems, Hanna Jokinen, Hugo Kuijf, Bonnie Y. K. Lam, Jessica Lebenberg, Bradley J. MacIntosh, Pauline Maillard, Vincent C. T. Mok, Leonardo Pantoni, Salvatore Rudilosso, Claudia L. Satizabal, Markus D. Schirmer, Reinhold Schmidt, Colin Smith, Julie Staals, Michael J. Thrippleton, Susanne J. van Veluw, Prashanthi Vemuri, Yilong Wang, David Werring, Marialuisa Zedde, Rufus O. Akinyemi, Oscar H. Del Brutto, Hugh S. Markus, Yi-Cheng Zhu, Eric E. Smith, Martin Dichgans, Joanna M. Wardlaw

Summary: Cerebral small vessel disease (SVD) is a common age-related condition that can cause stroke, cognitive decline, neurobehavioral symptoms, and functional impairment. STRIVE-1 classified and standardized the various visible features of SVD on structural MRI, but new information and imaging techniques have emerged since then. Quantitative imaging biomarkers and machine learning methods offer a more comprehensive understanding of the impact of SVD on the brain and can serve as intermediary outcomes in clinical trials and routine practice.

LANCET NEUROLOGY (2023)

Article Neurosciences

Optimizing detection of Alzheimer's disease in mild cognitive impairment: a 4-year biomarker study of mild behavioral impairment in ADNI and MEMENTO

Zahinoor Ismail, Rebeca Leon, Byron Creese, Clive Ballard, Philippe Robert, Eric E. Smith

Summary: This study investigated the association between mild behavioral impairment (MBI) in mild cognitive impairment (MCI) and Alzheimer's disease (AD), and found that adding MBI to MCI can better identify AD and improve dementia prognostication. Therefore, the addition of MBI is important for the detection of AD.

MOLECULAR NEURODEGENERATION (2023)

Article Cardiac & Cardiovascular Systems

Prevalence of heart failure stages in the general population and implications for heart failure prevention: reports from the China Hypertension Survey 2012-15

Anping Cai, Congyi Zheng, Jiayuan Qiu, Gregg C. Fonarow, Gregory Y. H. Lip, Yingqing Feng, Zengwu Wang

Summary: The burden of heart failure (HF) in China is expected to increase due to population ageing. However, there is limited knowledge about the prevalence of HF stages in China. Therefore, this study aimed to evaluate the prevalence of HF stages in the general Chinese population and the specific prevalence by age, sex, and urbanity. The study found that both pre-clinical and clinical HF burdens are high in China and vary by age, sex, and urbanity.

EUROPEAN JOURNAL OF PREVENTIVE CARDIOLOGY (2023)

Article Cardiac & Cardiovascular Systems

Cardiac Autonomic Dysfunction and Risk of Silent Myocardial Infarction Among Adults With Type 2 Diabetes

Arnaud D. Kaze, Gregg C. Fonarow, Justin B. Echouffo-Tcheugui

Summary: In a large cohort of adults with type 2 diabetes, the study found a significant association between cardiac autonomic neuropathy (CAN) and the risk of silent myocardial infarction (SMI). Low heart rate variability was significantly associated with an increased risk of incident SMI. Participants with CAN had a 1.9-fold greater risk of SMI.

JOURNAL OF THE AMERICAN HEART ASSOCIATION (2023)

Article Neurosciences

A qualitative study of barriers and facilitators to using tenecteplase to treat acute ischemic stroke

Sidarrth Prasad, Erica M. Jones, Mehari Gebreyohanns, Veronica Aguilera, DaiWai M. Olson, Jane A. Anderson, Sean I. Savitz, Salvador C. Flores, Steven J. Warach, Charlotte E. Rhodes, Mark P. Goldberg, Nneka L. Ifejika

Summary: This study identified the barriers and facilitators to adopting tenecteplase (TNK) as a thrombolytic treatment for acute ischemic stroke (AIS) by conducting qualitative research with stroke clinicians in Texas. The findings suggest that providing evidence and identifying key change processes can help clinicians achieve consensus on adopting TNK for AIS treatment.

JOURNAL OF STROKE & CEREBROVASCULAR DISEASES (2024)

No Data Available